|
|||
|
Radiation Research Program |
Laredo Medical Center
|
||
|
Grant Staff Contact Information
Executive Secretary Patient Navigator Grant Administrator/Manager |
Primary Partner Institution Co-Investigators James M. Hevezi, PhD Tony Yuen Eng, MD Secondary Partner Institution Co-Investigator |
Healthcare institutions providing cancer services to a disproportionate number of medically underserved, low income and/or minority populations, whether urban or rural, are often not linked effectively to national cancer research protocols. This application seeks funding to support the planning, development and implementation of radiation oncology clinical research trials in the predominately Hispanic population of Laredo, Texas. Despite recent advances in cancer care and therapies there is a disproportionate burden borne by this minority population in South Texas. Laredo has a population of 176,576. Ninety-five percent of those residents are Hispanic. It is geographically isolated with no other U.S. cities within a 140-mile radius. The Sanchez Cancer Center, housed at Laredo Medical Center, is a state of the art cancer center with both medical and radiation oncology facilities. Since its doors opened in November 1999, 475 patients have been treated with radiation therapy. Ninety-four percent of these patients were Hispanic. The potential partner institutions selected for collaboration with the applicant institution, are University of Texas Health Science Center in San Antonio (UTHSCSA) and its Cancer Therapy and Research Center (CTRC) and M.D. Anderson Cancer Center (MDACC) in Houston, Texas. MHC has a long history of collaboration and partnership with the CTRC, a NCI designated comprehensive Cancer Center comprised of the University of Texas Health Science Center in San Antonio and the San Antonio Cancer Institute in San Antonio, Texas. MDACC is also a NCI recognized Comprehensive Cancer Center. The strength of this proposal is that it unites the oncology research experience of the partner institutions with access provided to the Hispanic cancer patient population through MHC. The Sanchez Cancer Center is well equipped and staffed to carryout any collaborative clinical trials generated through this grant. Tele-conference will be used extensively to facilitate collaboration. This study will meet the requirements for planning, development, and implementation of clinical trials in an area with vast need for this type of research. This proposal will yield invaluable data and information on cancer outcomes and treatment strategies to improve cancer morbidity and mortality outcomes in Hispanic populations.
Laredo Medical Center's Patient Navigator Program
Programmatic Goals :
Diminish cancer morbidity and mortality in our Hispanic population
by providing services at all lengths along the cancer continuum.
The program will assist patients in coping with all aspects of a
cancer diagnosis.
Patient Navigator Responsibilities:
Contact Information
Patient Navigator
Norma Grisel Mejia, MSW
Phone: (956) 796-4740
Email: norma_mejia@chs.net
See also: Rapid City Regional Hospital, Rapid City, South Dakota
Details of Laredo Medical Center's Patient Navigator Program were taken from the Patient Navigator Plan entitled the "NCI Patient Navigator Program" submitted to the Radiation Research Program by Dr. Yadvindera Bains. (January 30, 2003)